Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Xuping Xie; Yang Liu; Jianying Liu; Xianwen Zhang; Jing Zou; Camila R Fontes-Garfias; Hongjie Xia; Kena A Swanson; Mark Cutler; David Cooper; Vineet D Menachery; Scott C Weaver; Philip R Dormitzer; Pei-Yong Shi

doi:10.1038/s41591-021-01270-4

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Nat Med. 2021 Apr;27(4):620-621. doi: 10.1038/s41591-021-01270-4. Epub 2021 Feb 8.

Authors

Xuping Xie^#¹, Yang Liu^#¹, Jianying Liu^#^{2

3}, Xianwen Zhang¹, Jing Zou¹, Camila R Fontes-Garfias¹, Hongjie Xia¹, Kena A Swanson⁴, Mark Cutler⁴, David Cooper⁴, Vineet D Menachery^{2

3}, Scott C Weaver^{2

3}, Philip R Dormitzer⁵, Pei-Yong Shi^{6

7

8

9

10}

Affiliations

¹ Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
² Departments of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
³ Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
⁴ Pfizer, Pearl River, NY, USA.
⁵ Pfizer, Pearl River, NY, USA. philip.dormitzer@pfizer.com.
⁶ Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. peshi@utmb.edu.
⁷ Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA. peshi@utmb.edu.
⁸ Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, USA. peshi@utmb.edu.
⁹ Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. peshi@utmb.edu.
¹⁰ Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. peshi@utmb.edu.

^# Contributed equally.

PMID: 33558724
DOI: 10.1038/s41591-021-01270-4

Abstract

We engineered three severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viruses containing key spike mutations from the newly emerged United Kingdom (UK) and South African (SA) variants: N501Y from UK and SA; 69/70-deletion + N501Y + D614G from UK; and E484K + N501Y + D614G from SA. Neutralization geometric mean titers (GMTs) of 20 BTN162b2 vaccine-elicited human sera against the three mutant viruses were 0.81- to 1.46-fold of the GMTs against parental virus, indicating small effects of these mutations on neutralization by sera elicited by two BNT162b2 doses.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines / immunology*
Humans
Mutation*
Neutralization Tests*
SARS-CoV-2 / immunology*
Spike Glycoprotein, Coronavirus / genetics*
Spike Glycoprotein, Coronavirus / immunology
Vaccination

Substances

COVID-19 Vaccines
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
BNT162 Vaccine

Abstract

Publication types

MeSH terms

Substances

Grants and funding